Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02839694
Title Adjuvant Oral Decitabine and Tetrahydrouridine With or Without Celecoxib in People Undergoing Pulmonary Metastasectomy
Recruitment Withdrawn
Gender both
Phase Phase I
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

germ cell cancer

sarcoma

melanoma

Therapies

Decitabine + Tetrahydrouridine

Celecoxib + Decitabine + Tetrahydrouridine

Age Groups: adult | senior
Covered Countries


No variant requirements are available.